Excited-state observation of active K-Ras reveals differential structural dynamics of wild-type versus oncogenic G12D and G12C mutants
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Excited-state observation of active K-Ras reveals differential structural dynamics of wild-type versus oncogenic G12D and G12C mutants ; volume:30 ; number:10 ; day:28 ; month:8 ; year:2023 ; pages:1446-1455 ; date:10.2023
Nature structural & molecular biology ; 30, Heft 10 (28.8.2023), 1446-1455, 10.2023
- Creator
-
Hansen, Alexandar L.
Xiang, Xinyao
Yuan, Chunhua
Bruschweiler-Li, Lei
Brüschweiler, Rafael
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41594-023-01070-z
- URN
-
urn:nbn:de:101:1-2024010809414168540461
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hansen, Alexandar L.
- Xiang, Xinyao
- Yuan, Chunhua
- Bruschweiler-Li, Lei
- Brüschweiler, Rafael
- SpringerLink (Online service)
Other Objects (12)
The relationship between oncogenic KRas and wild-type Ras activity and signaling
The Importance of Mg 2+ ‐Free State in Nucleotide Exchange of Oncogenic K‐Ras Mutants
Immune modulatory effects of oncogenic KRAS in cancer
Oncogenic KRAS promotes malignant brain tumors in zebrafish
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges
Structure and inhibitor binding characterization of oncogenic MLLT1 mutants
FOLFIRI plus panitumumab in the treatment of wild-type KRAS and wild-type NRAS metastatic colorectal cancer
Oncogenic KRAS renders cells resistant to ferroptosis by upregulating FSP1
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Controlling oncogenic KRAS signaling pathways with a Palladium-responsive peptide
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
The relationship between oncogenic KRas and wild-type Ras activity and signaling
The Importance of Mg 2+ ‐Free State in Nucleotide Exchange of Oncogenic K‐Ras Mutants
Immune modulatory effects of oncogenic KRAS in cancer
Oncogenic KRAS promotes malignant brain tumors in zebrafish
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges
Structure and inhibitor binding characterization of oncogenic MLLT1 mutants
FOLFIRI plus panitumumab in the treatment of wild-type KRAS and wild-type NRAS metastatic colorectal cancer
Oncogenic KRAS renders cells resistant to ferroptosis by upregulating FSP1
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Controlling oncogenic KRAS signaling pathways with a Palladium-responsive peptide
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
The relationship between oncogenic KRas and wild-type Ras activity and signaling
The Importance of Mg 2+ ‐Free State in Nucleotide Exchange of Oncogenic K‐Ras Mutants
Immune modulatory effects of oncogenic KRAS in cancer
Oncogenic KRAS promotes malignant brain tumors in zebrafish
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges
Structure and inhibitor binding characterization of oncogenic MLLT1 mutants
FOLFIRI plus panitumumab in the treatment of wild-type KRAS and wild-type NRAS metastatic colorectal cancer
Oncogenic KRAS renders cells resistant to ferroptosis by upregulating FSP1
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Controlling oncogenic KRAS signaling pathways with a Palladium-responsive peptide